| Literature DB >> 35501767 |
Kosuke Miyazawa1, Susumu Sakimoto2,3, Masanori Kanai1, Akihiko Shiraki1, Shizuka Takahashi1, Nobuhiko Shiraki1, Kazuichi Maruyama1, Hirokazu Sakaguchi1,4, Kohji Nishida1,5.
Abstract
BACKGROUND: This study aimed to evaluate macular vessel tortuosity using optical coherence tomography angiography (OCTA) and its association with visual outcomes in eyes undergoing surgery for epiretinal membrane (ERM).Entities:
Keywords: Epiretinal membrane; Imaging analysis; Optical coherence tomography angiography; Vascular tortuosity; Vitrectomy
Mesh:
Year: 2022 PMID: 35501767 PMCID: PMC9063110 DOI: 10.1186/s12886-022-02420-z
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.086
Fig. 1Representative en face image of optical coherence tomography angiography (OCTA) shows microvascular structure around the macula in a right eye with epiretinal membrane. a A 6 × 6 mm en face image of OCTA is divided into four quadrants. b A high magnification image of the red square in (a). A retinal vessel was randomly picked in each quadrant to macula descending to macula. We also picked two adjacent branch points. Red dotted line represents the actual vessel length in the vessel section and yellow line represents the direct vessel branching point distance between two adjacent branch points
Patient characteristics
| Parameter | Value |
|---|---|
| Mean age ± SD, yrs | 72.05 ± 8.86 (57–88) |
| Gender, n (male/female) | 7/15 |
| Axial length (mm) | 23.55 ± 0.87 (22.51 to 25.71) |
| Preoperative phakic / IOL | 19/3 |
| ERM stage 1:2:3:4 | 1:3:13:5 |
| Internal Limiting Membrane Dye | |
| Triamcinolone | 17 |
| Indocyanine green | 5 |
| Preoperative logMAR BCVA | 0.21 ± 0.25(−0.18 to 0.82) |
| Postoperative logMAR BCVA | |
| 1 month | 0.13 ± 0.21(−0.18 to 0.70) |
| 3 months | 0.08 ± 0.19(−0.18 to 0.52) |
| 6 months | 0.02 ± 0.19(− 0.18 to 0.40) |
| Preoperative central macular thickness (μm) | 431.0 ± 98.4 (260 to 628) |
| Postoperative central macular thickness (μm) | |
| 1 month | 412.0 ± 52.6 (333 to 498) |
| 3 months | 390.6 ± 49.3 (308 to 496) |
| 6 months | 383.1 ± 45.1 (316 to 496) |
| Preoperative foveal avascular zone area (mm2) | 0.081 ± 0.068 (0.020 to 0.300) |
| Postoperative foveal avascular zone area (mm2) | |
| 1 month | 0.074 ± 0.035 (0.025 to 0.136) |
| 3 months | 0.079 ± 0.037 (0.028 to 0.152) |
| 6 months | 0.079 ± 0.037 (0.029 to 0.161) |
SD Standard deviation, IOL Intraocular lens, ERM Epiretinal membrane, logMAR Logarithm of the Minimum Angle of Resolution, BCVA Best-corrected visual acuity
Vascular changes measured by OCTA
| The actual vessel length in area (VL) (um) | Value | |
|---|---|---|
| Temporal | ||
| preoperative | 1375.9 ± 577.9 | |
| 1 M | 1421.2 ± 547.7 | 0.006 |
| 3 M | 1429.3 ± 550.6 | 0.008 |
| 6 M | 1419.8 ± 564.9 | 0.022 |
| Nasal | ||
| preoperative | 1147.8 ± 293.6 | |
| 1 M | 1111.5 ± 267.9 | 0.046 |
| 3 M | 1105.7 ± 274.1 | 0.018 |
| 6 M | 1115.5 ± 270.5 | 0.083 |
| Superior + Inferior | ||
| preoperative | 1322.6 ± 509.6 | |
| 1 M | 1344.6 ± 501.0 | 0.052 |
| 3 M | 1342.8 ± 499.6 | 0.061 |
| 6 M | 1344.5 ± 493.3 | 0.053 |
OCTA Optical coherence tomography angiography, 1 M 1 month, 3 M 3 months, 6 M 6 months
Fig. 2Representative en face images of preoperative and postoperative optical coherence tomography angiography (OCTA) in eyes with ERM. a Preoperative and b postoperative 1 month 6 × 6 mm OCTA images. Red dotted lines show temporal and nasal vessels analyzed in this study. High magnification images are shown below, which correspond to the dotted yellow square. The length of red dotted lines defined as “the actual vessel length (VL)” and the length of red lines defined as “the direct vessel branching point distance (BD),” respectively. Note that VL becomes shorter in temporal vessels and longer in nasal vessels postoperatively. In contrast, BD becomes longer in temporal and shorter in nasal postoperatively
Factors associated with VL/BD in the univariate analysis
| Temporal | Nasal | Superior + Inferior | ||||
|---|---|---|---|---|---|---|
| Coefficient | Coefficient | Coefficient | ||||
| BCVA | ||||||
| 1 M | − 0.046 | 0.838 | − 0.143 | 0.525 | 0.318 | 0.035 |
| 3 M | − 0.012 | 0.959 | 0.115 | 0.61 | 0.319 | 0.035 |
| 6 M | −0.05 | 0.827 | 0.033 | 0.885 | 0.307 | 0.042 |
| CMT | ||||||
| 1 M | 0.14 | 0.534 | 0.257 | 0.249 | 0.075 | 0.627 |
| 3 M | 0.444 | 0.044 | 0.058 | 0.803 | 0.144 | 0.364 |
| 6 M | 0.382 | 0.088 | −0.186 | 0.421 | 0.074 | 0.641 |
| FAZ | ||||||
| 1 M | −0.31 | 0.16 | −0.26 | 0.242 | −0.001 | 0.998 |
| 3 M | −0.295 | 0.183 | 0.042 | 0.854 | 0.029 | 0.853 |
| 6 M | −0.263 | 0.236 | 0.174 | 0.438 | 0.095 | 0.541 |
VL Actual vessel length, BD Direct vessel branching point distance, BCVA Best corrected visual acuity, CMT Central macular thickness, FAZ Foveal avascular zone, 1 M 1 month, 3 M 3 months, 6 M 6 months
Fig. 3Scatter plots of data summary described in Tables 3 and 4. a Scatter plots depicting the association between superior/inferior VL/BD and BCVA postoperatively at 1 month (1 M), 3 months (3 M), and 6 months (6 M), which was shown in Table 3. Lines show regression lines. b Scatter plots depicting the association between the change of VL in the nasal quadrant and the change of BCVA postoperatively at 1 month (1 M), 3 months (3 M), and 6 months (6 M), which was shown in Table 4. Lines show regression lines. VL: the actual vessel length, BD: the direct vessel branching point distance, BCVA: best-corrected visual acuity
Factors associated with the change in the actual vascular length in univariate analysis
| Temporal | Nasal | Superior + Inferior | ||||
|---|---|---|---|---|---|---|
| Coefficient | Coefficient | Coefficient | ||||
| Preoperative BCVA | ||||||
| 1 M | −0.001 | 0.996 | −0.436 | 0.042 | 0.133 | 0.389 |
| 3 M | 0.046 | 0.84 | −0.489 | 0.021 | 0.014 | 0.926 |
| 6 M | −0.094 | 0.677 | −0.471 | 0.027 | −0.038 | 0.805 |
| ΔBCVA | ||||||
| 1 M | −0.173 | 0.442 | 0.343 | 0.118 | −0.2 | 0.193 |
| 3 M | −0.188 | 0.402 | 0.497 | 0.0189 | −0.182 | 0.238 |
| 6 M | −0.04 | 0.861 | 0.423 | 0.0455 | −0.017 | 0.911 |
| ΔCMT | ||||||
| 1 M | −0.544 | 0.009 | 0.116 | 0.608 | −0.182 | 0.238 |
| 3 M | −0.422 | 0.057 | 0.373 | 0.096 | −0.272 | 0.082 |
| 6 M | −0.296 | 0.193 | 0.384 | 0.086 | −0.34 | 0.027 |
| ΔFAZ | ||||||
| 1 M | 0.174 | 0.438 | 0.058 | 0.796 | 0.193 | 0.211 |
| 3 M | 0.21 | 0.348 | 0.015 | 0.949 | 0.199 | 0.194 |
| 6 M | 0.088 | 0.696 | 0.12 | 0.595 | 0.193 | 0.21 |
BCVA Best corrected visual acuity, CMT Central macular thickness, FAZ Foveal avascular zone, 1 M 1 month, 3 M 3 months, 6 M 6 months